Clinical Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
EQ | D | Equillium, Inc. | -15.00 | |
CPIX | F | Cumberland Pharmaceuticals Inc. | -11.49 | |
SVRA | D | Savara, Inc. | -8.19 | |
LIXT | F | Lixte Biotechnology Holdings, Inc. | -5.89 | |
LXRX | D | Lexicon Pharmaceuticals, Inc. | -5.29 | |
ONCT | D | Oncternal Therapeutics, Inc. | -5.28 | |
FGEN | F | FibroGen, Inc | -4.92 | |
BLRX | F | BioLineRx Ltd. | -4.83 | |
NXTC | D | NextCure, Inc. | -4.07 | |
SAGE | F | Sage Therapeutics, Inc. | -3.57 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
BBP | C | BioShares Biotechnology Products Fund | 3.81 | |
PSIL | F | AdvisorShares Psychedelics ETF | 2.89 | |
LABD | D | Direxion Daily S&P Biotech Bear 3X Shares | 2.85 | |
BIS | D | ProShares UltraShort Nasdaq Biotechnology | 0.95 | |
XBI | D | SPDR S&P Biotech ETF | 0.62 |
Compare ETFs
- Clinical Development
Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles